Renal transplantation in the ANCA-associated vasculitides

American Journal of Transplantation

Volumn 7, Issue 12, 2007, Pages 2657-2662

  Geetha, D ^a   Seo, P ^b  

^a JOHNS HOPKINS UNIVERSITY   (United States)

^b JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

ANCA; Immunosuppression; Kidney; Recurrence; Transplant; Vasculitis

Indexed keywords

ADALIMUMAB; AZATHIOPRINE; CD20 ANTIBODY; CYCLOPHOSPHAMIDE; CYCLOSPORIN; ETANERCEPT; IMMUNOSUPPRESSIVE AGENT; INFLIXIMAB; INTERLEUKIN 2 RECEPTOR ANTIBODY; LEFLUNOMIDE; METHOTREXATE; MONOCLONAL ANTIBODY; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; NEUTROPHIL CYTOPLASMIC ANTIBODY; PREDNISONE; RITUXIMAB; T LYMPHOCYTE ANTIBODY;

ANCA ASSOCIATED VASCULITIS; ANTIBODY TITER; DIABETES MELLITUS; DISEASE EXACERBATION; GLOMERULONEPHRITIS; GRAFT SURVIVAL; HEMODIALYSIS; HUMAN; IMMUNE COMPLEX NEPHRITIS; IMMUNOSUPPRESSIVE TREATMENT; KIDNEY FAILURE; KIDNEY GRAFT REJECTION; KIDNEY TRANSPLANTATION; LOW DRUG DOSE; LUPUS ERYTHEMATOSUS NEPHRITIS; MICROSCOPIC POLYANGIITIS; MORBIDITY; PATHOGENESIS; PERITONEAL DIALYSIS; PRIORITY JOURNAL; RECURRENCE RISK; RECURRENT DISEASE; SHORT SURVEY; SURVIVAL; SURVIVAL RATE; SURVIVAL TIME; THERAPY DELAY; TREATMENT CONTRAINDICATION; TREATMENT INDICATION; WEGENER GRANULOMATOSIS;

ANTIBODIES, ANTINEUTROPHIL CYTOPLASMIC; HUMANS; KIDNEY FAILURE, CHRONIC; KIDNEY TRANSPLANTATION; RECURRENCE; RENAL DIALYSIS; TREATMENT OUTCOME; VASCULITIS;

EID: 35748972923     PISSN: 16006135     EISSN: 16006143     Source Type: Journal    
DOI: 10.1111/j.1600-6143.2007.01988.x     Document Type: Short Survey

References (51)

1. Watts RA, Carruthers DM, Scott DG. Epidemiology of systemic vasculitis: Changing Incidence or Definiton Semin Arthritis Rheum 1995 25 : 29 34.
2. Jayne DR, Marshall PD, Jones SJ, Lockwood CM. Autoantiboides to GBM and neutrophils cytoplasm in rapidly progressive glomerulonephritis. Kidney Int 1990 37 : 965 970.
3. Allen A, Pusey C, Gaskin C. Outcome of renal replacement therapy in antineutrophil cytoplasmic antibody associated systemic vasculitis. J Am Soc Nephrol 1998 9 : 1258 1263.
4. Westman KW, Bygren PG, Olsson H, Ranstam J, Wieslander J. Relapse rate, renal survival and cancer morbidity in patients with Wegener's granulomatosis or microscopic polyangiitis with renal involvement. J Am Soc Nephrol 1998 9 : 842 852.
5. Van Der Woude FJ, Rasmussen N, Lobatto S et al. Autoantibodies against neutrophils and monocytes: Tool for diagnosis and marker of disease activity in Wegener's granulomatosis. Lancet 1985 1 : 425 429.
6. Falk RJ, Hoffman GS. Controversies in small vessel vasculitis - comparing the rheumatology and nephrology views. Curr Opin Rheumatol 2007 19 : 1 9.
7. Xiao H, Heeringa P, Hu P et al. Antineutrophil cytoplasmic autoantibodies specific for myeloperoxidase cause glomerulonephritis and vasculitis in mice. J Clin Invest 2002 110 : 995 963.
8. Weidemann S, Andrassy K, Ritz E. ANCA in hemodialysis patients. Nephrol Dial Transplant 1993 8 : 839 845.
9. Nissenson A, Port F. Outcome of end stage renal disease in patients with rare causes of renal failure.III.Systemic/vascular disorders. Q J Med 1990 74 : 63 74.
10. Haubitz M, Koch KM, Brunkhorst R. Survival and vasculitis activity in patients with end-stage renal disease due to Wegener's granulomatosis. Nephrol Dial Transplant 1998 13 : 1713 1718.
11. Kuross S, Davin T, Kjellstrand CM. Wegener's granulomatosis with severe renal failure: Clinical course and results of dialysis and transplantation. Clin Nephrol 1981 16 : 172 180.
12. Schmitt WH, Haubitz M, Mistry N, Brunkhorst R, Erbsloh-Moller B, Gross WL. Renal transplantation in Wegener's granulomatosis. Lancet 1993 342 : 860.
13. Haubitz M, Kleim V, Koch KM et al. Renal transplantation for patients with autoimmune diseases: single-center experience for 42 patients. Transplantation 1997 63 : 1251 1257.
14. Lyons GW, Lindsay WG. Renal transplantation in a patient with Wegener's granulomatosis. Am J Surg 1972 124 : 104 107.
15. Schnuelle P, Lorenz D, Trede M, Van Der Woude FJ. Impact of renal cadaveric transplantation on survival in end -stage renal failure: Evidence for reduced mortality risk compared with hemodialysis during long term follow up. J Am Soc Nephrol 1998 9 : 2135 2141.
16. Wolfe RA, Ashby VB, Milford EL et al. Comparison of mortality in all patient on dialysis, patients on dialysis awaiting transplantation and recipients of a first cadaveric transplant. N Engl J Med 1999 341 : 1725 1730.
17. Schmitt WH, Opelz G, Van Der Woude FJ. Renal transplantation is safe and successful in Wegener's granulomatosis: Data from the Colloborative Transplant Study. J Am Soc Nephrol 2002 13 : 564A 565A.
18. Deegens JKJ, Artz MA, Hoitsma AJ, Wetzels JFM. Outcome of renal transplantation in patients with pauci-immune small vessel vasculitis or anti-GBM disease. Clin Nephrol 2003 59 : 1 9.
19. Elmedhem A, Adu D, Savage CO. Relapse rate and outcome of ANCA-associated small vessel vasculitis after transplantation. Nephrol Dial Transplant 2003 18 : 1001 1004.
20. Steinman TI, Jaffe BF, Monaco AP, Wolff SM, Fauci AS. Recurrence of Wegener's granulomatosis after kidney transplantation: Successful Re-induction of remission with cyclophosphamide. Am J Med 1980 68 : 458 460.
21. Nachman PH, Segelmark M, Westman K et al. Recurrent ANCA-associated small vessel vasculitis after transplantation: A pooled analysis. Kidney Int 1999 56 : 1544 1550.
22. Reaich D, Cooper N, Main J. Rapid catastrophic onset of Wegener's granulomatosis in a renal transplant. Nephron 1994 67 : 354 357.
23. Rich LM, Piering WF. Ureteral stenosis due to recurrent Wegener's granulomatosis after kidney transplantation. J Am Soc Nephrol 1994 4 : 1516 1521.
24. Curtis JJ, Diethelm AG, Herrera GA, Crowell WT, Whelchel JD. Recurrence of Wegener's granulomatosis in a cadaver renal allograft. Transplantation 1983 36 : 452 454.
25. Fan SLS, Lewis KE, Ball E, Dodd S, Raftery M, Yaqoob MM. Recurrence of Wegener's granulomatosis 13 years after renal transplantation. Am J Kidney Dis 2001 38 : E32.
26. Noel L, Morin M, Theevet E et al. Successful kidney transplantation in a patient with microscopic polyarteritis and positive ANCA (abstract). Clin Exp Immunol 1993 93 : 43.
27. Grotz W, Wanner C, Rother E, Schollmeyer P. Clinical course of patients with antineutrophil cytoplasm antibody positive vasculitis after kidney transplantation. Nephron 1995 69 : 234 236.
28. Frasca GM, Neri L, Martello M, Sestigiani E, Borgnino LC, Bonomini V. Renal transplantation in patients with microscopic polyarteritis and antimyeloperoxidae antibodies: Report of three cases. Nephron 1996 72 : 82 85.
29. Nyberg G, Akesson P, Norden G, Wieslander J. Systemic vasculitis in a kidney transplant population. Transplantation 1997 63 : 1273 1277.
30. Rostaing L, Modesto A, Oksman F, Cisterne JM, Le Mao G, Durand D. Outcome of patients with antineutrophil cytoplasmic autoantibody-associated vasculitis following cadaveric kidney transplantation. Am J Kidney Dis 1997 29 : 96 102.
31. Tervaert JW, Van Der Woude FJ, Fauci AS et al. Association between active Wegener's granulomatosis and anticytoplasmic antibodies. Arch Intern Med 1989 149 : 2461 2465.
32. Finkielman JD, Merkel PA, Schroeder D et al. Antineutrophil cytoplasmic antibodies against Proteinase 3 do not predict disease relapses in Wegener's granulomatosis. Arthritis Rheum 2006 (Suppl).
33. Tervaert JW, Huitema MG, Hene RJ et al. Prevention of relapses in Wegener's granulomatosis by treatment based on antineutrophil cytoplasmic antibody titre. Lancet 1990 336 : 709 711.
34. Boomsma MM, Stegeman CA, Van Der Leij MJ et al. Prediction of relapses in Wegener's granulomatosis by measurement of antineutrophil cytoplasmic antibody levels. Arthritis Rheum 2000 43 : 2025 2033.
35. Clarke AE, Bitton A, Eappen R, Danoff DS, Esdaile JM. Treatment of Wegener's granulomatosis after renal transplantation: Is cyclosporine the preferred treatment Transplantation 1990 50 : 1047 1050.
36. Stassen PM, Cohen Tervaert JW, Stegeman CA. Induction of remission in active ANCA-associated vasculitis with mycophenolate mofetil in patients who cannot be treated with cyclophosphamide. Ann Rheum Dis 2006 1 17.
37. Nowack R, Gobel U, Klooker P, Hergesell O, Andrassy K, vander Woude FJ. Mycophenolate mofetil for maintenance therapy of Wegener's granulomatosis and microscopic polyangiitis : A pilot study in 11 patients with renal involvement. J Am Soc Nephrol 1999 10 : 1965 1971.
38. Langford CA, Talar-Williams C, Sneller MC. Mycophenolate Mofetil for remission maintenance in the treatment of Wegener's granulomatosis. Arthritis Rheum 2004 51 : 278 283.
39. Schmitt W, Opelz G, Van Der Woude FJ. Clinical course of Wegener's granulomatosis following renal transplantation: New data from the collaborative Transplant Study. J Am Soc Nephrol 2006 17 :
40. Gera M, Griffin MD, Specks U, Leung N, Stegall MD, Fervenza FC. Recurrence of ANCA associated vasculitis following renal transplantation in the modern era of immunosuppression. Kidney Int 2007 78 : 1 6.
41. Moroni G, Torri A, Gallelli B et al. The long term prognosis of renal transplant in patients with systemic vasculitis. Am J Transplant 2007 7 : 2133 2139.
42. Turnet JH, Adu D, Michael J, McMaster P. Recurrent crescentic glomerulonephritis in renal transplant recipient treated with cyclosporine. Lancet 1986 1 : 1104.
43. Rosenstein ED, Ribot S, Ventresca E, Kramer N. Recurrence of Wegener's granulomatosis following renal transplantation. Br J Rheumatol 1994 33 : 869 871.
44. Hoffman GS, Kerr GS, Leavitt RY et al. Wegener's granulomatosis: An analysis of 158 patients. Annals Intern Med 1992 116 : 488 98.
45. Metzler C, Miehle N, Manger K et al. Relapse rate under oral methotrexate versus leflunomide for maintenance of remission in Wegener's granulomatosis. Rheumatology 2007 46: 1087-1091.
46. Seo P, Stone JH. Small and Medium Vessel Vasculitis. Arthritis Rheum 2007 in press).
47. Keogh KA, Ytterberg SR, Fervenza FC, Carlson KA, Schroeder DR, Specks U. Rituximab for refractory Wegener's granulomatosis: Report of a prospective, open-label pilot trial. Am J Respir Crit Care Med 2006 173 : 180 187.
48. Stasi R. Stipa E, Del Poeta G, Amadori S, Newland AC, Provan D. Long term observation of patients with anti-neutrophil cytoplasmic antibody-associated vasculitis treated with rituximab. Rheumatology 2006 45 : 1432 1436.
49. Omdal R, Wildhagen K, Hansen T, Gunnarsson R, Kristoffersen G. Anto-CD20 therapy for resistant Wegener's granulomatosis: Favourable but temporary response. Scand J Rheumatol 2005 34 : 229 232.
50. Goblin JM, Keogh KA, Fervenza FC, Ytterberg SR, Specks U. Repeated use of rituximab in refractory Wegener's granulomatosis: Efficacy for glucocorticoid-free remission maintenance. Arthritis Rheum 2006 56 (Supplement).
51. Freim Wahl SG, Folvik MR, Torp SH. Progressive multifocal leukoencephalopathy in a lymphoma patient with complete remission after treatment with cytostatics and rituximab: case report and review of the literature. Clin Neuropathol 2007 26 : 68 73.